SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
about
SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
SPRY2 is a novel MET interacto ...... entiation in rhabdomyosarcoma.
@en
SPRY2 is a novel MET interacto ...... entiation in rhabdomyosarcoma.
@nl
type
label
SPRY2 is a novel MET interacto ...... entiation in rhabdomyosarcoma.
@en
SPRY2 is a novel MET interacto ...... entiation in rhabdomyosarcoma.
@nl
prefLabel
SPRY2 is a novel MET interacto ...... entiation in rhabdomyosarcoma.
@en
SPRY2 is a novel MET interacto ...... entiation in rhabdomyosarcoma.
@nl
P2860
P1476
SPRY2 is a novel MET interacto ...... rentiation in rhabdomyosarcoma
@en
P2093
Aakanksha Verma
P2860
P356
10.1038/S41419-018-0261-2
P577
2018-02-14T00:00:00Z